Search for Clinical Trial Results

Sponsored By

Polycystic Kidney, Autosomal Recessive - 4 Studies Found

Status Study
Not yet recruiting Study Name: A Safety, Pharmacokinetic, Single Ascending Dose Study of Tesevatinib in Pediatric Subjects With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Condition: Polycystic Kidney, Autosomal Recessive
Date: 2017-03-06
Interventions: Drug: Tesevatinib One dose of the study drug in liquid form
Not yet recruiting Study Name: UAB Recessive PKD Research and Translational Core Center
Condition: Autosomal Recessive Polycystic Kidney Disease
Date: 2007-12-13
Active, not recruiting Study Name: Clinical and Molecular Investigations Into Ciliopathies
Condition:
  • Autosomal Recessive Polycystic Kidney Disease
  • Congenital Hepati
    Date: 2003-09-10
Recruiting Study Name: UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Condition:
  • Hepato/Renal Fibrocystic Disease
  • Autosomal Recessive Polycystic Kidney
    Date: 2011-07-22